Clinical Trials
2 trialsNCT06274788 2025-09-05
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Recruiting
NCT04807478 2022-08-04
Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Fresenius Kabi
Withdrawn